Showing results (771-780 of 1,839) with videos related to

Sort By:
Pageof 184
ESMO Open|April 13, 2024
Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastasesM Tonello, D Baratti, P Sammartino, et al.
ESMO Open|January 24, 2026
Global advances and future directions in lung cancer care: expert consensus and strategic prioritiesM-L Meyer, S Peters, P A Jänne, et al.
ESMO Open|January 21, 2026
Mutational patterns and ancestry-linked profiles in a large hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma cohortC Gerdes, S Rengarajan, K Murugesan, et al.
ESMO Open|February 13, 2026
NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trialT Macarulla, R Pazo Cid, M S Womack, et al.
ESMO Open|February 13, 2026
Prediction model for ctDNA detectability in liquid comprehensive genomic profiling of advanced pancreatic cancer based on Japanese real-world dataH Ikushima, K Watanabe, A Shinozaki-Ushiku, et al.
ESMO Open|February 3, 2026
Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regressionG M Iannantuono, T Giovagnoli, L Mastrantoni, et al.
ESMO Open|January 28, 2026
Progression-free survival 2 (PFS2) as a surrogate endpoint for overall survival (OS) in breast cancer randomized controlled clinical trialsP Filis, N Filis, T Foukakis, et al.
ESMO Open|January 28, 2026
Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohortE Terán, R Pazo, L Caritá, et al.
ESMO Open|February 17, 2026
Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancerY Katayama, A Fukuda, R Inoue, et al.
ESMO Open|November 26, 2025
Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib studyS Kuemmel, K H Jung, L Andrade, et al.
Pageof 184